// App-Quantinova.ai

: Pegfilgrastim Versus Filgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone

Researchers

Presenter

  • Claudio Cerchione

Principal Investigators

  • Davide Nappi

  • Gerardo Musuraca

  • Sonia Ronconi

  • Delia Cangini

  • Michela Ceccolini

  • Giovanni Martinelli

Medical Centers

  • University of Naples Federico II, Napoli, ITA

  • Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Neutropenia

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pegfilgrastim

  • Pomalidomide

  • CC-4047

  • Filgrastim

Outcome

  • N/A

Study Design

  • Efficacy

  • Safety

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved